Form 4: CVS Health Executive Sreekanth K. Chaguturu Reports Stock Transaction
SEC Form 4 Filing
EVP and Chief Medical Officer of CVS Health, Sreekanth K. Chaguturu, reports the surrender of shares to cover withholding taxes upon vesting of a restricted stock award.
Summary
- On February 26, 2024, Sreekanth K. Chaguturu, EVP and Chief Medical Officer of CVS Health Corp, reported a transaction involving common stock.
- The transaction involved the surrender of 355 shares to cover withholding taxes due upon the vesting of a restricted stock award.
- The price per share was $76.43.
- Following the transaction, Chaguturu directly owns 9,333.9847 shares of CVS Health Corp.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a routine transaction related to executive compensation and tax obligations. It doesn't indicate any positive or negative sentiment regarding the company's performance or future prospects.
Industry Context
This is a routine Form 4 filing, which is common for corporate executives who receive stock-based compensation. It provides transparency into insider transactions and helps maintain market integrity.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Date of stock transaction (surrender of shares). |
| 02/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.